Association between increased iron stores and impaired endothelial function in patients with hereditary hemochromatosis

Journal of the American College of Cardiology

Volumn 40, Issue 12, 2002, Pages 2189-2194

  Gaenzer, Hannes ^a   Marschang, Peter ^a   Sturm, Wolfgang ^a   Neumayr, Günther ^a   Vogel, Wolfgang ^a   Patsch, Josef ^a   Weiss, Günter ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

CERULOPLASMIN; CHOLESTEROL; FERRITIN; GLUTATHIONE; GLYCEROL NITRATE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; THIOBARBITURIC ACID REACTIVE SUBSTANCE; TRANSFERRIN; TRIACYLGLYCEROL;

ADULT; ARTICLE; ATHEROSCLEROSIS; B SCAN; BRACHIAL ARTERY; CARDIOVASCULAR DISEASE; CHEMICAL ANALYSIS; CLINICAL ARTICLE; COMMON CAROTID ARTERY; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENETIC DISORDER; HEMOCHROMATOSIS; HEMODYNAMIC PARAMETERS; HUMAN; INTIMA; IRON METABOLISM; IRON OVERLOAD; MALE; OXIDATIVE STRESS; PHLEBOTOMY; PRIORITY JOURNAL; THICKNESS; TUNICA MEDIA; VASCULAR ENDOTHELIUM; VASODILATATION;

ADULT; BRACHIAL ARTERY; CAROTID ARTERIES; CORONARY ARTERIOSCLEROSIS; ENDOTHELIUM, VASCULAR; FEMALE; HEMOCHROMATOSIS; HUMANS; MALE; MIDDLE AGED; OXIDATIVE STRESS; PHLEBOTOMY; RISK FACTORS; SEX FACTORS; THIOBARBITURIC ACID REACTIVE SUBSTANCES; TUNICA INTIMA; TUNICA MEDIA; VASODILATION;

EID: 0037132637     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(02)02611-6     Document Type: Article

References (36)

1. Lum H, Roebuck KA. Oxidant stress and endothelial dysfunction. Am J Physiol (Cell Physiol) 2001;280:C719-41.
2. Steinberg D, Parthasarathy S, Carew TE, et al. Beyond cholesterol: Modification of low-density lipoprotein that increase its atherogenicity. N Engl J Med 1989;320:915-24.
3. Salonen JT, Nyyssonen K, Korpela H, et al. High stored iron levels are associated with excess risk of myocardial infarction in eastern Finnish men. Circulation 1992;86:803-11.
4. Magnusson MK, Thorgeirsson G. Low iron-binding capacity as a risk factor for myocardial infarction. Circulation 1994;89:102-8.
5. Tuomainen TP, Salonen R, Nyyssonen K, Salonen JT. Cohort study of relation between donating blood and risk of myocardial infarction in 2682 men in eastern Finland. BMJ 1997;314:793-4.
6. Baer DM, Tekawa IS, Hurley LB. Iron stores are not associated with acute myocardial infarction. Circulation 1994;89:2915-8.
7. Sempos CT, Looker AC, Gillum RF, et al. Body iron stores and the risk of coronary heart disease. N Engl J Med 1994;330:1119-24.
8. Liao Y, Cooper RS, McGee DL. Iron status and coronary heart disease: Negative findings from the NHANES I epidemiologic follow-up study. Am J Epidemiol 1994;139:704-12.
9. Ascherio A, Willett WC, Rimm EB, et al. Dietary iron intake and risk of coronary disease among men. Circulation 1994;89:969-74.
10. Roest M, van der Schouw YT, de Valk B, et al. Heterozygosity for a hereditary hemochromatosis gene is associated with cardiovascular mortality in women. Circulation 1999;100:1268-73.
11. Tuomainen TP, Kontula K, Nyyssonen K, et al. Increased risk of acute myocardial infarction in carriers of the hemochromatosis gene Cys282Tyr mutation: A prospective cohort study in men in eastern Finland. Circulation 1999;100:1274-9.
12. O'Leary DH, Polak JF, Kronmal RA, et al. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. N Engl J Med 1999;340:14-22.
13. Kiechl S, Aichner F Gerstenbrand, et al. Body iron stores and presence of carotid atherosclerosis: Results from the Bruneck study. Arterioscler Thromb 1994;14:1625-30.
14. Kiechl S, Willeit J, Egger G, et al. Body iron stores and the risk of carotid atherosclerosis: prospective results from the Bruneck study. Circulation 1997;96:3300-7.
15. Moore M, Folsom AR, Barnes RW, et al. No association between serum ferritin and asymptomatic carotid atherosclerosis: The Atherosclerosis Risk In Communities (ARIC) study. Am J Epidemiol 1995;141:719-23.
16. Ross R. The pathogenesis of atherosclerosis: A perspective for the 1990s. Nature 1993;362:801-9.
17. Celermajer DS, Sorensen KE, Gooch VM, et al. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet 1992;340:1111-5.
18. Simonsen K, Dissing J, Rudbeck L, et al. Rapid and simple determination of hereditary haemochromatosis mutations by multiplex PCR-SSCP: Detection of a new polymorphic mutation. Ann Hum Genet 1999;63:193-7.
19. Gochee PA, Powell LW, Cullen DJ, Du Sart D, Rossi E, Olynyk JK. A population-based study of the biochemical and clinical expression of the H63D hemochromatosis mutation. Gastroenterology. 2002;122:646-51.
20. Adams P, Brissot P, Powell LW. EASL international consensus conference on haemochromatosis. J Hepatol 2000;33:485-504.
21. Gaenzer H, Neumayr G, Marschang P, et al. Flow-mediated vasodilation of the femoral and brachial artery induced by exercise in healthy nonsmoking and smoking men. J Am Coll Cardiol 2001;38:1313-9.
22. Buege JA, Aust SD. Microsomal lipid peroxidation. Methods Enzymol 1978;52:302-10.
23. Weiss G, Umlauft F, Urbanek M, et al. Associations between cellular immune effector function, iron metabolism, and disease activity in patients with chronic hepatitis C virus infection. J Infect Dis 1999;180:1452-60.
24. Erel O. Automated measurement of serum ferroxidase activity. Clin Chem 1998;44:2313-9.
25. Weiss G, Werner-Felmayer G, Werner ER, et al. Iron regulates nitric oxide synthase activity by controlling nuclear transcription. J Exp Med 1994;180:969-76.
26. Rooyakkers TM, Stroes ESG, Kooistra MP, et al. Ferric saccharate induces oxygen radical stress and endothelial dysfunction in vivo. Eur J Clin Invest 2002;32 Suppl 1:9-16.
27. Natarajan V. Oxidants and signal transduction in vascular endothelium. J Lab Clin Med 1995;125:26-37.
28. Duffy SJ, Biegelsen ES, Holbrook M, et al. Iron chelation improves endothelial function in patients with coronary artery disease. Circulation 2001;103:2799-804.
29. Sullivan JL. Iron and the genetics of cardiovascular disease (editorial). Circulation 1999;100:1260-3.
30. Failla M, Giannattasio C, Piperno A, et al. Radial artery wall alterations in genetic hemochromatosis before and after iron depletion therapy. Hepatology 2000;32:569-73.
31. Sullivan JL. Iron and the sex difference in heart disease risk. Lancet 1981;1:1293-4.
32. Salonen JT, Tuomainen TP, Salonen R, et al. Donation of blood is associated with reduced risk of myoardial infarction: The Kuopio ischaemic heart disease risk factor study. Am J Epidemiol 1998;148:445-51.
33. Sullivan JL. Iron therapy and cardiovascular disease. Kidney Int 1999;55 Suppl:135-7.
34. Hetet G, Elbaz A, Gariepy J, et al. Association studies between haemochromatosis gene mutations and the risk of cardiovascular diseases. Eur J Clin Invest 2001;31:382-8.
35. Weiss G. Iron and immunity: A double-edged sword. Eur J Clin Invest 2002;32:S70-8.
36. Evans P, Halliwell B. Micronutrients: Oxidant/antioxidant status. Br J Nutr 2001;85:S67-74.